Anika to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
Anika Therapeutics (NASDAQ: ANIK) announced their participation in the Morgan Stanley 19th Annual Global Healthcare Conference, taking place virtually on September 15, 2021, at 2:00 p.m. ET. Dr. Cheryl Blanchard, CEO, and Michael Levitz, CFO, will engage in a fireside chat. Investors can listen to the live audio webcast on Anika’s website under the Investor Relations section, with an archive available later. Anika focuses on early intervention orthopedics, creating minimally invasive products to enhance patient active living.
- None.
- None.
BEDFORD, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and Chief Executive Officer and Michael Levitz, Executive Vice President, Chief Financial Officer and Treasurer, will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on Thursday, September 15, 2021 at 2:00 p.m. ET.
A live audio webcast will be available in the Investor Relations section of Anika’s website, www.anika.com. An audio archive of the session will also be available on the website.
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. We partner with clinicians to understand what they need most to treat their patients and we develop minimally invasive products that restore active living for people around the world. We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies. Anika is headquartered in Massachusetts with operations in the United States and Europe. For more information about Anika, please visit www.anika.com.
For Investor Inquiries:
Mark Namaroff
Anika Therapeutics, Inc.
Executive Director, Investor Relations and Corporate Communications
Direct: 781-457-9287
mnamaroff@anika.com
FAQ
When is Anika Therapeutics participating in the Morgan Stanley Healthcare Conference?
Who will represent Anika Therapeutics at the conference?
How can investors access the Anika conference webcast?
What type of company is Anika Therapeutics?
What does Anika Therapeutics specialize in?
